UBS (UBS)
(Delayed Data from NYSE)
$28.03 USD
-1.13 (-3.88%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $28.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$28.03 USD
-1.13 (-3.88%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $28.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Zacks News
Strength Seen in Western New England Bancorp (WNEB): Can Its 7.8% Jump Turn into More Strength?
by Zacks Equity Research
Western New England Bancorp (WNEB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UBS Group (UBS), Mitsubishi to Sell Japanese Realty JV to KKR
by Zacks Equity Research
UBS Group (UBS) and Mitsubishi announce the divestiture of their Japanese real estate joint venture to KKR for $2 billion. The deal is set to increase Common Equity Tier 1 capital ratio.
Should Value Investors Buy These Finance Stocks?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Deutsche Bank (DB) Limits Exposure in Russia and Ukraine
by Zacks Equity Research
Deutsche Bank (DB) limits its exposure to Russia and Ukraine to avoid major impacts to its financials.
Should Investors Fret Over UBS Group's (UBS) Russian Exposure?
by Zacks Equity Research
UBS Group (UBS) reveals its $634-million exposure to Russia that has subsided since 2021 end.
UBS (UBS) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
UBS (UBS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UBS vs. CM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UBS vs. CM: Which Stock Is the Better Value Option?
Franklin (BEN) Rides on Strategic Buyouts, Higher Costs Ail
by Zacks Equity Research
Franklin's (BEN) efforts to expand via acquisitions and strong diversification strategies are commendable. Yet, higher expenses and a strict regulatory environment are major drags.
Why Is UBS (UBS) Down 14.7% Since Last Earnings Report?
by Zacks Equity Research
UBS (UBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Investors Fret Over Citi's (C) $9.8B Russian Exposure?
by Zacks Equity Research
Given its strong fundamentals, Citi's (C) disclosure of its approximate $10-billion exposure to Russia is not likely to affect its financials.
UBS Group (UBS) to Spruce Up Wealth Unit for the Affluent
by Zacks Equity Research
UBS Group (UBS) will create a new business unit to serve the super-rich by bringing together several services catering to the elite demographic.
What's in the Cards for Scotiabank (BNS) in Q1 Earnings?
by Zacks Equity Research
The Bank of Nova Scotia's (BNS) fiscal Q1 earnings results are likely to reflect higher margins and loan balance growth amid a recovering economy.
Zacks Value Trader Highlights: AutoNation, Inc., UBS, APA Corp., KB Home and Harley Davidson
by Zacks Equity Research
AutoNation, Inc., UBS, APA Corp., KB Home and Harley Davidson are highlighted in this Value Trader article.
Huntington (HBAN) Stock Poised for Growth: Should You Hold?
by Zacks Equity Research
Huntington's (HBAN) stock is worth keeping on a sound balance sheet position and inorganic growth moves. Yet, a concentrated loan portfolio and margin pressure are bothersome.
Reasons to Hold on to PNC Financial (PNC) Stock For Now
by Zacks Equity Research
PNC Financial's (PNC) strong balance sheet, inorganic expansion and sound capital deployment activities are positives. Yet, rising operating expenses and declining net interest margins ail.
5 Top Value Stocks with Strong Growth
by Tracey Ryniec
Value stocks that also have growth are a rare combination. Who are the companies that are doing it in 2022?
Diversification Supports Goldman (GS), Cost Woes Prevail
by Zacks Equity Research
Goldman Sachs (GS) is well-poised for growth on its sound IB revenue growth, a diversified product suite and steady capital-deployment initiatives. Yet, rising costs and a heavy reliance on overseas revenues are woes.
Barclays (BCS) Records Significant Y/Y Growth in Q4 Earnings
by Zacks Equity Research
Barclays (BCS) records a rise in revenues and expenses in the fourth quarter of 2021.
HSBC Q4 Pre-Tax Earnings Jump on Higher Revenues, Lower Costs
by Zacks Equity Research
HSBC records a rise in adjusted revenues in the fourth quarter of 2021. Adjusted expenses witness a y/y decline.
Here's Why It is Worth Holding on to U.S. Bancorp (USB) Stock
by Zacks Equity Research
U.S. Bancorp's (USB) stock is worth keeping on the grounds of a sound balance sheet, diverse revenue streams and inorganic growth moves. Yet, a concentrated loan portfolio and mounting costs bother.
Reasons to Hold on to New York Community (NYCB) Stock For Now
by Zacks Equity Research
New York Community's (NYCB) declining expense base and expansion of the banking-as-a-service space can support its financials. Yet, unsustainable capital deployment activities and high debt ail.
Synovus' (SNV) Organic Growth Profile Aids, Rising Costs Ail
by Zacks Equity Research
Despite bearing a concentrated loan portfolio, Synovus (SNV) is worth holding on to in your portfolio owing to its strategic initiatives and improving organic growth.
UBS vs. CM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UBS vs. CM: Which Stock Is the Better Value Option?
BNY Mellon's (BK) Low Cost, Solid AUM Aid, Margin Pressure Ails
by Zacks Equity Research
BNY Mellon's (BK) solid liquidity position, lower expenses and global footprints aid financials. However, concentration risk from dependence on fee-based revenues and margin pressure are concerning.
Here's Why HSBC is Scaling Back Swiss Private Banking Business
by Zacks Equity Research
HSBC Holdings (HSBC) is planning to trim its private bank workforce and lower office space in Switzerland to improve overall operating efficiency.